Literature DB >> 15855650

Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility.

Mariarosaria Boccellino1, Giovanni Camussi, Alfonso Giovane, Luigi Ferro, Vincenzo Calderaro, Ciro Balestrieri, Lucio Quagliuolo.   

Abstract

In the present study, we evaluated whether motility of Kaposi's sarcoma (KS) cells induced by platelet-activating factor (PAF) is dependent on the regulation of adherens junctions components. The results obtained indicate that PAF dose and time dependently reduced the endogenous expression of the main components of the adherens junctions: VE-cadherin, alpha-catenin, and beta-catenin. In addition, PAF initiated events that directly or indirectly up-regulated both the tyrosine and serine/threonine phosphorylation pathways, and both types of phosphorylation of beta-catenin were involved in the motility of KS cells. This motility was abrogated by addition of the tyrosine kinase inhibitor genistein, suggesting that this phosphorylation is an important signal responsible for breaking down the adherens junctions and diminishing the ability of neighboring cells to interact. Furthermore, immunofluorescence analysis showed that beta-catenin and VE-cadherin staining changed from a uniform distribution along the membrane of controls to a diffuse pattern with gap formation in PAF-treated KS cells. In conclusion, the data presented here indicate that PAF induces tumor cell motility by altering cell-cell adhesion through beta-catenin phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855650      PMCID: PMC1620029          DOI: 10.1016/s0002-9440(10)62367-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 2.  The cadherin-catenin adhesion system in signaling and cancer.

Authors:  Maralice Conacci-Sorrell; Jacob Zhurinsky; Avri Ben-Ze'ev
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  Regulation of beta-catenin structure and activity by tyrosine phosphorylation.

Authors:  J Piedra; D Martinez; J Castano; S Miravet; M Dunach; A G de Herreros
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

4.  Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.

Authors:  L Biancone; V Cantaluppi; M Boccellino; B Bussolati; L Del Sorbo; P G Conaldi; A Albini; A Toniolo; G Camussi
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Augmentation of tumor metastasis by platelet-activating factor.

Authors:  S Y Im; H M Ko; J W Kim; H K Lee; T Y Ha; H B Lee; S J Oh; S Bai; K C Chung; Y B Lee; H S Kang; S B Chun
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

6.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

Authors:  J Comijn; G Berx; P Vermassen; K Verschueren; L van Grunsven; E Bruyneel; M Mareel; D Huylebroeck; F van Roy
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

7.  A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions.

Authors:  M A Perez-Moreno; A Locascio; I Rodrigo; G Dhondt; F Portillo; M A Nieto; A Cano
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

Review 8.  Rho GTPases: signaling, migration, and invasion.

Authors:  A A Schmitz; E E Govek; B Böttner; L Van Aelst
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

9.  Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Authors:  Gunhild M Maelandsmo; Ruth Holm; Jahn M Nesland; Øystein Fodstad; Vivi Ann Flørenes
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

Review 10.  Regulation of cadherin adhesive activity.

Authors:  B M Gumbiner
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  12 in total

1.  CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin.

Authors:  Wei-Hsien Hou; I-Hua Liu; Cheng C Tsai; Frank E Johnson; Shuan Shian Huang; Jung San Huang
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

2.  Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion.

Authors:  Yan Du; Manlin Cao; Yiwen Liu; Yiqing He; Cuixia Yang; Man Wu; Guoliang Zhang; Feng Gao
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

3.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

4.  Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.

Authors:  Margarita Aponte; Wei Jiang; Montaha Lakkis; Ming-Jiang Li; Dale Edwards; Lina Albitar; Allison Vitonis; Samuel C Mok; Daniel W Cramer; Bin Ye
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

5.  Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.

Authors:  Lifang Zhang; Dan Wang; Wei Jiang; Dale Edwards; Weiliang Qiu; Lisa M Barroilhet; Jung-Hyun Rho; Lianjin Jin; Vanitha Seethappan; Allison Vitonis; Jianliu Wang; Samuel C Mok; Christopher Crum; Daniel W Cramer; Bin Ye
Journal:  Reprod Biol Endocrinol       Date:  2010-06-24       Impact factor: 5.211

6.  H9c2 Cardiomyocytes under Hypoxic Stress: Biological Effects Mediated by Sentinel Downstream Targets.

Authors:  Mariarosaria Boccellino; Giovanni Galasso; Pasqualina Ambrosio; Paola Stiuso; Stefania Lama; Erika Di Zazzo; Sonia Schiavon; Daniele Vecchio; Luca D'ambrosio; Lucio Quagliuolo; Antonia Feola; Giacomo Frati; Marina Di Domenico
Journal:  Oxid Med Cell Longev       Date:  2021-09-30       Impact factor: 6.543

7.  Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.

Authors:  Rihong Cong; Qingmin Sun; Li Yang; Haijuan Gu; Ying Zeng; Bin Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-09-07

8.  Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.

Authors:  Yi Yu; Xiaoyan Zhang; Shanshan Hong; Mingxing Zhang; Qingqing Cai; Wei Jiang; Congjian Xu
Journal:  J Ovarian Res       Date:  2014-04-11       Impact factor: 4.234

9.  Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.

Authors:  Fan Zhang; Lei Liu; Han Zhang; Zhe-Li Liu
Journal:  Drug Des Devel Ther       Date:  2020-10-12       Impact factor: 4.162

10.  Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.

Authors:  Yue Liao; Susann Badmann; Till Kaltofen; Doris Mayr; Elisa Schmoeckel; Eileen Deuster; Mareike Mannewitz; Sarah Landgrebe; Thomas Kolben; Anna Hester; Susanne Beyer; Alexander Burges; Sven Mahner; Udo Jeschke; Fabian Trillsch; Bastian Czogalla
Journal:  Biomedicines       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.